Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
Susan H. Eshleman(Johns Hopkins University), Myron S. Cohen(University of North Carolina at Chapel Hill), Ronald Swanstrom(University of North Carolina at Chapel Hill), Elena Dukhovlinova(University of North Carolina at Chapel Hill), Jessica M. Fogel(Johns Hopkins University), Thomas C. Quinn(Johns Hopkins University), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Devin Sabin(Johns Hopkins University), Estelle Piwowar‐Manning(Johns Hopkins University), Xinyi Cindy Zhang(Infectious Disease Research Institute), Nuntisa Chotirosniramit(Chiang Mai University), Victor Akelo(Centers for Disease Control and Prevention), James P. Hughes(University of Washington), Marybeth McCauley(Family Health International 360), Madalitso Maliwichi, Ravindre Panchia(Chris Hani Baragwanath Hospital), Laurence Gunde(University of Malawi), Craig Martens(National Institutes of Health), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Stephen F. Porcella(National Institutes of Health), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Daniel Bruno, Andrew D. Redd(Johns Hopkins University), Sikhulile Moyo(Harvard University), Matthew F. Sievers(Johns Hopkins University), Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), San-San Ou(Fred Hutch Cancer Center), Marineide Gonçalves de Melo(Hospital Nossa Senhora da Conceição), Sarah E. Hudelson(Johns Hopkins University), Li-Hua Ping(University of North Carolina at Chapel Hill), Nehemiah Nhando(University of Zimbabwe)
Cited by 78
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
|Neurology|1989|4.1k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k